{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:37:19Z","timestamp":1790375839909,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008052","name":"Fundaci\u00f3n Alfonso Mart\u00edn Escudero","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02065","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T04:20:47Z","timestamp":1568089247000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer"],"prefix":"10.3389","volume":"10","author":[{"given":"Vanessa","family":"Daza-Cajigal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana S.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Stahlschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhash","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Southgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan O.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13992","DOI":"10.1038\/ncomms13992","article-title":"Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection","volume":"7","author":"Eletto","year":"2016","journal-title":"Nat Commun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0378-1119(02)00398-0","article-title":"Signaling through the JAK\/STAT pathway, recent advances and future challenges","volume":"285","author":"Kisseleva","year":"2002","journal-title":"Gene"},{"key":"B3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1158\/0008-5472.CAN-04-1909","article-title":"Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells","volume":"64","author":"Papageorgiou","year":"2004","journal-title":"Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1038\/ncomms15440","article-title":"Acquired IFN\u03b3 resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions","volume":"8","author":"Sucker","year":"2017","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1023\/A:1023668705040","article-title":"Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis","volume":"8","author":"Chawla-Sarkar","year":"2003","journal-title":"Apoptosis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2326-6066.CIR-14-0098","article-title":"Cytotoxic T lymphocytes block tumor growth both by lytic activity and IFN\u03b3-dependent cell-cycle arrest","volume":"3","author":"Matsushita","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B9","first-page":"84","article-title":"Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma","volume":"9","author":"Propper","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1189\/jlb.0611308","article-title":"Natural killer cell-produced IFN-\u03b3 and TNF-\u03b1 induce target cell cytolysis through up-regulation of ICAM-1","volume":"91","author":"Wang","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj\/mn\/7800123","article-title":"Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells","volume":"9","author":"Eppihimer","year":"2002","journal-title":"Microcirculation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e23353","DOI":"10.4161\/jkst.23353","article-title":"The tumor suppressor function of STAT1 in breast cancer","volume":"2","author":"Koromilas","year":"2013","journal-title":"JAK-STAT"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s10875-013-9907-0","article-title":"B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency","volume":"33","author":"Bax","year":"2013","journal-title":"J Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/jmg.2009.072108","article-title":"Multiple cutaneous squamous cell carcinomas in a patient with interferon gamma receptor 2 (IFN gamma R2) deficiency","volume":"47","author":"Toyoda","year":"2010","journal-title":"J Med Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s10875-014-0098-0","article-title":"Pineal germinoma in a child with interferon-\u03b3 receptor 1 deficiency. case report and literature review","volume":"34","author":"Taramasso","year":"2014","journal-title":"J Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jpeds.2003.11.012","article-title":"HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency","volume":"144","author":"Camcioglu","year":"2004","journal-title":"J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1038\/srep03042","article-title":"JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations","volume":"3","author":"Ren","year":"2013","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.eururo.2016.07.049","article-title":"Targeted exome sequencing of the cancer genome in patients with very high-risk bladder cancer","volume":"70","author":"Longo","year":"2016","journal-title":"Eur Urol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0176181","DOI":"10.1371\/journal.pone.0176181","article-title":"Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion","volume":"12","author":"Albacker","year":"2017","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","article-title":"Toward a shared vision for cancer genomic data","volume":"375","author":"Grossman","year":"2016","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nprot.2015.123","article-title":"SIFT missense predictions for genomes","volume":"11","author":"Vaser","year":"2016","journal-title":"Nat Protoc"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/0471142905.hg0720s76","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","author":"Adzhubei","year":"2013","journal-title":"Curr Protoc Hum Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2105-15-5","article-title":"Quantitative prediction of the effect of genetic variation using hidden Markov models","volume":"15","author":"Liu","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.eururo.2011.02.022","article-title":"Immortalisation of normal human urothelial cells compromises differentiation capacity","volume":"60","author":"Georgopoulos","year":"2011","journal-title":"Eur Urol"},{"key":"B26","first-page":"583","article-title":"Normal human urothelial cells in vitro: proliferation and induction of stratification","volume":"71","author":"Southgate","year":"1994","journal-title":"Lab Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1242\/jcs.01042","article-title":"Role of PPAR and EGFR signalling in the urothelial terminal differentiation programme","volume":"117","author":"Varley","year":"2004","journal-title":"J Cell Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/gcc.22468","article-title":"Mutation patterns in genes encoding interferon signaling and antigen presentation: a pan-cancer survey with implications for the use of immune checkpoint inhibitors","volume":"56","author":"Budczies","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2017.09.027","article-title":"Anti-PD-L1\/TGF\u03b2R2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis","author":"Grenga","year":"2017","journal-title":"Urol Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of metastasis by NK cells","volume":"32","author":"L\u00f3pez-Soto","year":"2017","journal-title":"Cancer Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ebiom.2016.08.036","article-title":"Meta-analysis of the luminal and basal subtypes of bladder cancer and the identification of signature immunohistochemical markers for clinical use","volume":"12","author":"Dadhania","year":"2016","journal-title":"EBioMed"},{"key":"B33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cdd.2008.116","article-title":"FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation","volume":"16","author":"Varley","year":"2009","journal-title":"Cell Death Differ"},{"key":"B34","first-page":"286","article-title":"Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1","volume":"76","author":"Jackson","year":"1992","journal-title":"Immunology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.4049\/jimmunol.0803458","article-title":"Autophagy and its role in MHC-mediated antigen presentation","volume":"182","author":"Crotzer","year":"2009","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00262-018-2127-y","article-title":"Certain BCG-reactive responses are associated with bladder cancer prognosis","volume":"67","author":"Shan","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.eururo.2019.01.011","article-title":"Impact of immune and stromal infiltration on outcomes following bladder-sparing trimodality therapy for muscle-invasive bladder cancer","volume":"76","author":"Efstathiou","year":"2019","journal-title":"Eur Urol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13148-018-0536-6","article-title":"Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients","volume":"10","author":"Ahl\u00e9n Bergman","year":"2018","journal-title":"Clin Epigenetics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"70982","DOI":"10.18632\/oncotarget.20237","article-title":"Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance","volume":"8","author":"Ren","year":"2017","journal-title":"Oncotarget"},{"key":"B40","doi-asserted-by":"publisher","first-page":"110693","DOI":"10.18632\/oncotarget.22690","article-title":"Regulation of PD-1\/PD-L1 pathway and resistance to PD-1\/PDL1 blockade","volume":"8","author":"Bai","year":"2017","journal-title":"Oncotarget"},{"key":"B41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40425-017-0271-0","article-title":"Society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of bladder carcinoma","volume":"5","author":"Kamat","year":"2017","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T08:46:56Z","timestamp":1568969216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2019.02065"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02065","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"article-number":"2065"}}